Renaissance Technologies
VTVT icon

Renaissance Technologies’s vTv Therapeutics VTVT Stock Holding History

Renaissance Technologies’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$657K Buy
+17,454
New +$605K ﹤0.01% 2497
2022
Q2 		– Sell
-286
Closed -$8K – 4611
2022
Q1 		$8K Buy
+286
New +$8.57K ﹤0.01% 4029
2021
Q1 		– Sell
-1,888
Closed -$140K – 3749
2020
Q4 		$140K Buy
+1,888
New +$145K ﹤0.01% 3215
2020
Q3 		– Sell
-3,319
Closed -$299K – 3725
2020
Q2 		$299K Sell
3,319
-4,063
-55% -$401K ﹤0.01% 3043
2020
Q1 		$564K Buy
7,382
+6,415
+663% +$617K ﹤0.01% 2699
2019
Q4 		$66K Buy
+967
New +$58.7K ﹤0.01% 3365
2018
Q2 		– Sell
-495
Closed -$81K – 3556
2018
Q1 		$81K Sell
495
-880
-64% -$215K ﹤0.01% 3277
2017
Q4 		$331K Buy
1,375
+125
+10% +$28K ﹤0.01% 2998
2017
Q3 		$299K Sell
1,250
-597
-32% -$119K ﹤0.01% 2903
2017
Q2 		$367K Buy
1,847
+252
+16% +$52.5K ﹤0.01% 2844
2017
Q1 		$418K Buy
1,595
+72
+5% +$16.4K ﹤0.01% 2820
2016
Q4 		$294K Buy
1,523
+298
+24% +$68.5K ﹤0.01% 2916
2016
Q3 		$352K Buy
+1,225
New +$295K ﹤0.01% 2917

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies's VTVT Position: Q2 2026 in Review

Renaissance Technologies opened a new position in vTv Therapeutics (VTVT) in Q2 2026: 17,454 shares worth $657K. The stake represents ﹤0.01% of the portfolio and ranks #2497 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in VTVT as recently as Q1 2022.

Renaissance Technologies first reported a position in VTVT in Q3 2016 and has held it in 13 quarters since. 45 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Renaissance Technologies held 17,454 shares of vTv Therapeutics worth $657K as of Q2 2026.
  • vTv Therapeutics was a new Renaissance Technologies position in Q2 2026.
  • vTv Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2497 holding.
  • Renaissance Technologies first reported a position in vTv Therapeutics in Q3 2016 and has held it in 13 quarters since.
  • 45 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.